Obesity, fatty liver disease and intestinal microbiota

doi:10.3748/wjg.v20.i44.16452

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 44

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (28193)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

1112

WORD

220

HTML

22654

Figures (1-3)

213

Tables (1-1)

188

Sum=24387

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

641

Download

1317

Sum=1958

Publishing Process of This Article

Item

Count

Browse

1188

Download

660

Sum=1848

Nov 28, 2014 (publication date) through Nov 19, 2024

Times Cited of This Article

Times Cited (144)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Nov 28, 2014; 20(44): 16452-16463
Published online Nov 28, 2014. doi: 10.3748/wjg.v20.i44.16452

Full Size Figure Download Figure

Figure 3 Probable mechanisms of action of the antiobesity effects of modulated intestinal microbiota. CLA: Conjugated linoleic acid; Fiaf: Fasting-induced adipocyte factor.

Citation: Arslan N. Obesity, fatty liver disease and intestinal microbiota. World J Gastroenterol 2014; 20(44): 16452-16463
URL: https://www.wjgnet.com/1007-9327/full/v20/i44/16452.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i44.16452